Promethazine Hydrochloride And Dextromethorphan Hydrobromide Oral Solution
NDC Package 70436-155-41
Package Information
Promethazine Hydrochloride And Dextromethorphan Hydrobromide Oral Solution is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. Marketed by Slate Run Pharmaceuticals, Llc, this product is identified by NDC 70436-155 and is authorized under FDA application ANDA040649.
Identification & Billing
- RxCUI: 991528 - promethazine HCl 6.25 MG / dextromethorphan HBr 15 MG in 5 mL Oral Solution
- RxCUI: 991528 - dextromethorphan hydrobromide 3 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution
- RxCUI: 991528 - dextromethorphan HBr 15 MG / promethazine HCl 6.25 MG per 5 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70436 - Slate Run Pharmaceuticals, Llc
- 70436-155 - Promethazine Hydrochloride And Dextromethorphan Hydrobromide Oral Solution
- 70436-155-41 - 118 mL in 1 BOTTLE
- 70436-155 - Promethazine Hydrochloride And Dextromethorphan Hydrobromide Oral Solution
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (70436-155). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70436-155-41 identifies a specific commercial package of 118 ml in 1 bottle of Promethazine Hydrochloride And Dextromethorphan Hydrobromide Oral Solution, labeled by Slate Run Pharmaceuticals, Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Slate Run Pharmaceuticals, Llc on October 05, 2020. The current certification is valid through December 31, 2025.
How is this Slate Run Pharmaceuticals, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70436015541. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.